Abstract
Objective: This article aims to elaborate a review of the literature with relevant studies on the treatment of prostate cancer (CaP) involving radioderapia, chemotherapy and medicinal plants. Methods: A review of the literature was conducted in the databases: Scientific Electronic Library Online (SCIELO), PubMed and CAPES journals, using the descriptors: prostate cancer, medicinal plants, radiotherapy and chemotherapy, published between 2010 and 2018. Results: Radiotherapy (RT) is a method that uses beams of ionizing radiation capable of destroying or preventing the proliferation of tumor cells. Thus, new forms of therapies in this area are emerging, such as: androgenic exclusion, localized CaP, image-guided RT, ablative stereotactic RT, and three-dimensional conformal RT. Since chemoprevention is the best way, therefore, it reduces the chances of developing tumors from the use of medicines. In the case of CaP, the most chemopreventive drugs in clinical trials include those with 5-alpha reductase inhibitors that convert testosterone to dihydrotestosterone. In relation to phytotherapy, it is estimated that 60% of marketed anticancer drugs, or in clinical investigations, are derivatives of natural origin such as Crocus sativus, Euphorbia zovitsii, Achillea wilhelmsii, Urtica dioica, Medicago sativae, Psoralea corylifolia. Conclusion: Within this context, it was possible to show that all of these therapies cited in the text is an important tool for the treatment of prostate cancer, emphasizing that phytotherapy represents a hope for treatment with a lower side effect for men.